Sugio K, Nakagawara A, Sasazuki T
Department of Genetics, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Cancer. 1991 Mar 1;67(5):1384-8. doi: 10.1002/1097-0142(19910301)67:5<1384::aid-cncr2820670518>3.0.co;2-7.
Amplification of the N-myc gene in neuroblastoma correlates with advanced stage and poor prognosis. Association of the expression between N-myc and major histocompatibility complex (MHC) class I genes in 33 neuroblastomas obtained from Japanese children was investigated. Amplification of the N-myc gene was observed in two of five cases in Stage III, six of 11 cases in Stage IV, and one of five cases in Stage IV-S. In each case, the expression of N-myc gene was significantly increased. The expression was also increased in cases without amplification of the N-myc gene, the origin being from the suprarenal region. Expression of the MHC class I gene was significantly decreased in five of these nine with a high level of N-myc expression with amplification. These results suggest that the down-modulation of the MHC class I expression may be associated with the high level of expression and amplification of N-myc gene in the advanced stage of neuroblastoma.
神经母细胞瘤中N-myc基因的扩增与晚期及不良预后相关。我们研究了从日本儿童获取的33例神经母细胞瘤中N-myc与主要组织相容性复合体(MHC)I类基因之间的表达关联。在III期的5例中有2例、IV期的11例中有6例以及IV-S期的5例中有1例观察到N-myc基因的扩增。在每种情况下,N-myc基因的表达均显著增加。在无N-myc基因扩增且起源于肾上腺区域的病例中,表达也增加。在这9例N-myc高表达且有扩增的病例中,有5例MHC I类基因的表达显著降低。这些结果表明,MHC I类表达的下调可能与神经母细胞瘤晚期N-myc基因的高表达和扩增相关。